Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Wearable injectors industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends (USD Million & 000' Units)
2.1.2 Type trends (USD Million & 000' Units)
2.1.3 Device type trends
2.1.4 Technology trends
2.1.5 Application trends
2.1.6 End user trends
2.1.7 Regional trends (USD Million & 000' Units)
Chapter 3 Wearable Injectors Industry Insights
3.1 Industry landscape, 2018-2032
3.2 Industry ecosystem analysis
3.2.1 Vendor matrix
3.2.2 Distribution channel analysis
3.2.3 Profit margin trends
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing prevalence of chronic diseases
3.3.1.2 Technological advancements in wearable injectors
3.3.1.3 Increasing demand for home based healthcare due to COVID-19
3.3.1.4 Increasing Concern over the Hazards and Limitations Related to Needle stick injury
3.3.2 Industry pitfalls & challenges
3.3.2.1 Excessive cost of wearable injectors
3.3.2.2 Preference for alternative drug delivery systems
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By device type
3.4.3 By technology
3.4.4 By application
3.4.5 By end user
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 UK
3.6.4 China
3.6.5 India
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 Amgen Inc.
4.1.2 Medtronic Plc.
4.1.3 Tandem Diabetes Care
4.2 Competitive dashboard, 2022
4.3 Company matrix analysis, 2022
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Wearable Injectors Market, By Type
5.1 Key segment trends
5.2 On body
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.3 Off body
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
Chapter 6 Wearable Injectors Market, By Device Type
6.1 Key segment trends
6.2 Mechanical
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Electronic
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Wearable Injectors Market, By Technology
7.1 Key segment trends
7.2 Spring-based
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Motor-driven
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Rotary pump
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Expanding battery
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.6 Others
7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Wearable Injectors Market, By Application
8.1 Key segment trends
8.2 Oncology
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Diabetes
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Cardiovascular diseases
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Autoimmune diseases
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.6 Others
8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Wearable Injectors Market, By End User
9.1 Key segment trends
9.2 Hospitals & clinics
9.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3 Homecare settings
9.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.4 Others
9.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 10 Wearable Injectors Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Poland
10.3.7 Austria
10.3.8 Denmark
10.3.9 Switzerland
10.3.10 The Netherlands
10.3.11 Czech Republic
10.3.12 Sweden
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Thailand
10.4.7 Indonesia
10.4.8 Vietnam
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Colombia
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Iran
Chapter 11 Company Profiles
11.1 United Therapeutics, Inc.
11.2 Amgen Inc.
11.3 Insulet Corporation
11.4 West Pharmaceutical Services, Inc.
11.5 Enable Injections
11.6 CeQur SA
11.7 Ypsomed
11.8 Subcuject
11.9 Tandem diabetes care
11.10 Eitan Medical
11.11 Medtronic Plc.
